Portal de Periódicos da CAPES

Realized Benefits from Switching Drugs

1992; University of Chicago Press; Volume: 35; Issue: 2 Linguagem: Inglês

10.1086/467258

1537-5285

Peter Temin,

Pharmaceutical studies and practices

Previous articleNext article No AccessRealized Benefits from Switching DrugsPeter TeminPeter TeminPDFPDF PLUS Add to favoritesDownload CitationTrack CitationsPermissionsReprints Share onFacebookTwitterLinkedInRedditEmail SectionsMoreDetailsFiguresReferencesCited by The Journal of Law and Economics Volume 35, Number 2Oct., 1992 Sponsored by The University of Chicago Booth School of Business and The University of Chicago Law School Article DOIhttps://doi.org/10.1086/467258 Views: 10Total views on this site Citations: 18Citations are reported from Crossref Copyright 1992 The University of ChicagoPDF download Crossref reports the following articles citing this article:Martha M. Rumore Chapter 4: Legal and Regulatory Issues in Self-Care Pharmacy Practice, (Nov 2020).https://doi.org/10.21019/9781582123172.ch4Monica Hildegard Otto, Carla Pillarella, Claudio Jommi The Economic Impact of a Switch From Prescription-Only to Non-prescription Drugs in Italy, Frontiers in Pharmacology 9 (Oct 2018).https://doi.org/10.3389/fphar.2018.01069Joshua Noone, Christopher M. Blanchette The value of self-medication: summary of existing evidence, Journal of Medical Economics 21, no.22 (Nov 2017): 201–211.https://doi.org/10.1080/13696998.2017.1390473Hoe Sang Chung, Min Kim , Applied Economics Letters 25, no.1818 ( 2018): 1316.https://doi.org/10.1080/13504851.2017.1420868Martha M. Rumore Chapter 4: Legal and Regulatory Issues in Self-Care Pharmacy Practice, (Dec 2017).https://doi.org/10.21019/9781582122656.ch4Natalie J. Gauld, Fiona S. Kelly, Nahoko Kurosawa, Linda J. M. Bryant, Lynne M. Emmerton, Stephen A. Buetow, Meijia Zhang Widening Consumer Access to Medicines through Switching Medicines to Non-Prescription: A Six Country Comparison, PLoS ONE 9, no.99 (Sep 2014): e107726.https://doi.org/10.1371/journal.pone.0107726J. Flanigan Public Bioethics, Public Health Ethics 6, no.22 (Jul 2013): 170–184.https://doi.org/10.1093/phe/pht022Richard P. Rozek Switching Pharmaceutical Products from Prescription to Over-the-Counter: The Debate in the U.S., European Journal of Risk Regulation 3, no.44 (Jan 2017): 601–607.https://doi.org/10.1017/S1867299X00002531E P Brass, R Lofstedt, O Renn Improving the Decision-Making Process for Nonprescription Drugs: A Framework for Benefit–Risk Assessment, Clinical Pharmacology & Therapeutics 90, no.66 (Nov 2011): 791–803.https://doi.org/10.1038/clpt.2011.231L. Douglas Ried, Sally A. Huston, Suzan N. Kucukarslan, Elliott M. Sogol, Kenneth W. Schafermeyer, Sujit S. Sansgiry Risks, benefits, and issues in creating a behind-the-counter category of medications, Journal of the American Pharmacists Association 51, no.11 (Jan 2011): 26–39.https://doi.org/10.1331/JAPhA.2011.10134Gila E. Fruchter, Murali K. Mantrala Proactive Planning of the Timing of a Partial Switch of a Prescription to Over-the-Counter Drug, Production and Operations Management 19, no.55 (Aug 2010): 614–628.https://doi.org/10.1111/j.1937-5956.2010.01135.x Davina C. Ling , Ernst R. Berndt , and Margaret K. Kyle Deregulating Direct‐to‐Consumer Marketing of Prescription Drugs: Effects on Prescription and Over‐the‐Counter Product Sales Ling/Berndt/Kyle, The Journal of Law and Economics 45, no.S2S2 (Jul 2015): 691–723.https://doi.org/10.1086/368004Theodore E. Keeler, Teh-wei Hu, Alison Keith, Richard Manning, Martin D. Marciniak, Michael Ong, Hai-Yen Sung The benefits of switching smoking cessation drugs to over-the-counter status, Health Economics 11, no.55 (Jan 2002): 389–402.https://doi.org/10.1002/hec.677Lars Noah Challenges in the Federal Regulation of Pain Management Technologies, SSRN Electronic Journal (Jan 2002).https://doi.org/10.2139/ssrn.326584Albert A. Okunade The Impact of 1990 Medicaid Drug Rebates Policy on Access to Prescriptions, Journal of Health & Social Policy 12, no.33 (Oct 2008): 33–51.https://doi.org/10.1300/J045v12n03_03Françoise G Pradel, Abraham G Hartzema, Elizabeth J Mutran, Christine Hanson-Divers Physician Over-the-Counter Drug Prescribing Patterns: An Analysis of the National Ambulatory Medical Care Survey, Annals of Pharmacotherapy 33, no.44 (Jun 2016): 400–405.https://doi.org/10.1345/aph.18247R.William Soller Evolution of self-care with over-the-counter medications, Clinical Therapeutics 20 (Jan 1998): C134–C140.https://doi.org/10.1016/S0149-2918(98)80018-0Anthony M. Marino Regulation of product safety design through product testing, Journal of Regulatory Economics 7, no.33 (May 1995): 255–276.https://doi.org/10.1007/BF01067097